NEU 3.15% $21.27 neuren pharmaceuticals limited

Ann: Trofinetide significant clinical benefit in Rett syndrome, page-42

  1. 5,791 Posts.
    lightbulb Created with Sketch. 735
    but still not convinced the results are enough for a really favourable deal or a fire under the SP.

    Sorry buddy but not sure which announcement you are reading. "Significant clinical benefit' which was proven statistically significant.
    Apart from a heading - Retts elmininated, not sure which part puts you off.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$21.27
Change
0.650(3.15%)
Mkt cap ! $2.718B
Open High Low Value Volume
$20.84 $21.56 $20.76 $7.760M 364.5K

Buyers (Bids)

No. Vol. Price($)
2 1378 $21.24
 

Sellers (Offers)

Price($) Vol. No.
$21.29 218 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.